MedTrace Logo

Extended Endoscopic Approaches to Non-malignant Maxillary Sinus Lesions Comparative

NCT05494099 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2022-08-09

No results posted yet for this study

Summary

The aim of this study is to compare the outcomes of endoscopic middle meatus mega-antrostomy, endoscopic pre-lacrimal recess approach and endoscopic modified medial maxillectomy regarding: 1.Assessment of the accessibility of each approach to visualize and reach the different walls and recesses of the maxillary sinus. 2. Any intraoperative or postoperative complications. 3. Any post-operative recurrence or residue detected by endoscopic examination. 4. Symptomatic relief by pre- and post-operative Sino-Nasal Outcome Test 22, Arabic translation and validation (SNOT-22) which is a reliable and valid outcome measure for CRS patients.

Conditions

  • Maxillary Sinus Disease
  • Approach-Approach Conflict

Interventions

PROCEDURE

endoscopic maxillary mega-antrostomy

a mucosal sparing technique that facilitates mucus clearance and sinus irrigation in terminally dysfunctional maxillary sinuses. EMMA involves extending the antrostomy through the posterior half of the inferior turbinate down to the floor of the nose, creating a significantly enlarged antrostomy.

PROCEDURE

Endoscopic Modified Medial Maxillectomy

In this approach, the maxillary sinus is operated upon, while the inferior turbinate and nasolacrimal duct are preserved.

PROCEDURE

Modified endoscopic pre-lacrimal approach

The approach involves making a curved mucosal incision on the lateral nasal wall just anterior to the head of the inferior turbinate. The nasal mucosa was then undermined off the lateral nasal wall. The maxillary sinus was entered with a chisel, and the medial bony wall of the maxillary sinus removed.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Hassan Mu Hegazy, MD · Tanta University Hospital, Egypt.

  • Ahmed Mo Gamea, MD · Tanta University Hospital, Egypt.

  • Mohamed Os Tomom, MD · Tanta University Hospital, Egypt.

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2023-11-30
Completion
2024-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05494099 on ClinicalTrials.gov